ZA9810371B - Th2 cell depletion; compositions; methods. - Google Patents

Th2 cell depletion; compositions; methods.

Info

Publication number: ZA9810371B
Authority: ZA; South Africa
Prior art keywords: compositions; methods; cell depletion; depletion; cell
Prior art date: 1997-11-13

Application number

ZA9810371A

Inventor

Hortensia Soto-Trejo

Joseph A Hedrick

Albert Zlotnik

Monica Napolitano

Original Assignee

Schering Corp

Monica Napolitano

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-13

Filing date

1998-11-12

Publication date

1999-08-30

1998-11-12 Application filed by Schering Corp, Monica Napolitano filed Critical Schering Corp

1999-08-30 Publication of ZA9810371B publication Critical patent/ZA9810371B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

ZA9810371A 1997-11-13 1998-11-12 Th2 cell depletion; compositions; methods. ZA9810371B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6539297P	1997-11-13	1997-11-13

Publications (1)

Publication Number	Publication Date
ZA9810371B true ZA9810371B (en)	1999-08-30

Family

ID=22062409

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9810371A ZA9810371B (en)	1997-11-13	1998-11-12	Th2 cell depletion; compositions; methods.

Country Status (7)

Country	Link
EP (1)	EP1030865A2 (en)
JP (1)	JP2001523446A (en)
AR (1)	AR016681A1 (en)
AU (1)	AU1373099A (en)
CA (1)	CA2309761A1 (en)
WO (1)	WO1999025734A2 (en)
ZA (1)	ZA9810371B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7157418B1 (en)	1998-07-22	2007-01-02	Osprey Pharmaceuticals, Ltd.	Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
US6416954B1 (en) *	1999-02-08	2002-07-09	Schering Corporation	Modulating Th2 cell levels via vMIP-I/CCR8 interaction
US6762341B2 (en)	2000-02-10	2004-07-13	Schering Corporation	Uses of mammalian CCR8 receptors and related reagents
AU2001236802A1 (en) *	2000-02-10	2001-08-20	Schering Corporation	Novel uses of mammalian ccr8 receptors and related reagents
WO2003096020A2 (en) *	2002-05-13	2003-11-20	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
WO2007044756A2 (en) *	2005-10-11	2007-04-19	Icos Corporation	Monoclonal antibodies recognizing human ccr8
WO2014082993A2 (en) *	2012-11-30	2014-06-05	Galapagos Nv	Molecular targets and compounds, and methods to identify the same, useful in the down-regulation of the th2 response
WO2017198631A1 (en) *	2016-05-16	2017-11-23	Istituto Nazionale Di Genetica Molecolare - Ingm	Markers selectively deregulated in tumor-infiltrating regulatory t cells
MX2021007576A (en) *	2018-12-27	2021-08-24	Shionogi & Co	NEW ANTI-RECEPTOR 8 ANTIBODY FOR CHEMOKINE C-C MOTIF (CCR8).
EP4103285A2 (en)	2020-02-14	2022-12-21	Jounce Therapeutics, Inc.	Antibodies and fusion proteins that bind to ccr8 and uses thereof
WO2023219147A1 (en) *	2022-05-13	2023-11-16	塩野義製薬株式会社	Novel anti-ccr8 antibodies for detecting ccr8

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4364932A (en) *	1979-09-18	1982-12-21	Ortho Pharmaceutical Corporation	Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same
DK0843557T3 (en) *	1995-07-21	2003-03-10	Inst Nat Sante Rech Med	Methods for detection, identification, isolation and selective labeling and targeting of Th1 lymphocytes using LAG-3 protein
JP3144805B2 (en) *	1996-06-05	2001-03-12	株式会社ビー・エム・エル	Human Th2-specific protein and gene encoding the same (B19) and transformants, recombinant vectors and monoclonal antibodies related thereto

1998
- 1998-11-12 ZA ZA9810371A patent/ZA9810371B/en unknown
- 1998-11-12 AU AU13730/99A patent/AU1373099A/en not_active Abandoned
- 1998-11-12 EP EP98957483A patent/EP1030865A2/en not_active Withdrawn
- 1998-11-12 WO PCT/US1998/023240 patent/WO1999025734A2/en not_active Ceased
- 1998-11-12 JP JP2000521113A patent/JP2001523446A/en active Pending
- 1998-11-12 CA CA002309761A patent/CA2309761A1/en not_active Abandoned
- 1998-11-12 AR ARP980105731A patent/AR016681A1/en unknown

Also Published As

Publication number	Publication date
EP1030865A2 (en)	2000-08-30
JP2001523446A (en)	2001-11-27
WO1999025734A2 (en)	1999-05-27
WO1999025734A3 (en)	1999-07-15
CA2309761A1 (en)	1999-05-27
AU1373099A (en)	1999-06-07
AR016681A1 (en)	2001-07-25

Publication	Publication Date	Title
GB2323700B (en)	2000-08-23	Electrochemical cells
ZA984849B (en)	1999-12-06	Compositions.
SG63814A1 (en)	1999-03-30	Thin type cell
ZA978256B (en)	1998-03-23	Electrolyte.
ZA965381B (en)	1997-12-29	Electrochemical cell.
ZA9811153B (en)	2000-06-07	An improved alkaline solid block composition.
ZA988142B (en)	2000-03-22	Cosmetic composition.
ZA971182B (en)	1997-08-27	Electrochemical cell.
MXPA01002531A (en)	2003-07-14	Cosmetic composition.
EP0681339A3 (en)	1996-03-27	Electrochemical cell.
AU7562898A (en)	1998-09-08	Photovoltaic cell
ZA9810371B (en)	1999-08-30	Th2 cell depletion; compositions; methods.
EP0662722A3 (en)	1997-02-19	Solar cell arrangement.
GB2348047B (en)	2001-04-11	Electrochemical cells
ZA9811502B (en)	2000-06-15	Novel composition.
ZA988586B (en)	2000-03-22	Truncated cellulase compositions.
ZA200006118B (en)	2002-01-30	Novel composition.
ZA981893B (en)	1999-09-06	Chemical composition.
ZA200000192B (en)	2000-08-07	Novel composition.
AU6139298A (en)	1998-08-25	Photovoltaic cell
EP0930361A4 (en)	2000-04-19	Cell compositions
GB9919227D0 (en)	1999-10-20	Solar cell
ZA981739B (en)	1999-09-02	Composition.
ZA991792B (en)	1999-09-16	Mouthwash composition.
ZA99925B (en)	1999-08-05	Composition.